Leap Brings New Grid Revenue Pathways to Technology Providers Through California Expansion
Expanded virtual power plant offerings in California will bolster grid reliability amid rising electricity prices and energy demand SAN FRANCISCO–(BUSINESS... Read more.
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”
An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision AUSTIN, Texas–(BUSINESS WIRE)–$IPA... Read more.
Matter Launches Tailored Tech PR Solutions for Fast, Strategic Results
Agency’s project-based PR offerings for B2B tech brands provide flexible program customization to improve visibility and drive on-message media coverage BOSTON–(BUSINESS... Read more.
Rothman Orthopaedics Selects Surgimate to Unify Surgical Scheduling Across Locations
PHILADELPHIA–(BUSINESS WIRE)–Rothman Orthopaedics, a world in leader in the field of orthopedics as well as the largest private musculoskeletal practice... Read more.
Walmart+ Celebrates 5th Anniversary with Expanded Video Streaming Choices
BENTONVILLE, Ark.–(BUSINESS WIRE)–Walmart+ is offering members greater control over their entertainment experience by introducing an enhanced video streaming... Read more.
mRNA Therapeutics Contract Development & Manufacturing Organization Business Research 2025-2030 | Growing Shift Towards Modular and Automated Manufacturing Solutions Promotes Growth and Efficiency – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “mRNA Therapeutics Contract Development & Manufacturing Organization – Global Strategic Business Report”... Read more.
Transcat to Participate in the D.A. Davidson 24th Annual Diversified Industrials & Services Conference on September 18
ROCHESTER, N.Y.–(BUSINESS WIRE)–Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration,... Read more.
Ori Biotech’s IRO® Platform Receives FDA Advanced Manufacturing Technology (AMT) Designation
AMT designation provides developers using IRO with earlier and more frequent FDA engagement, accelerating regulatory filings and patient access PHILADELPHIA &... Read more.
Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Trial demonstrated the feasibility of treating and monitoring adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) in an outpatient... Read more.
CSG Systems International to Hold Third Quarter 2025 Earnings Conference Call on November 5
DENVER–(BUSINESS WIRE)–CSG® (NASDAQ: CSGS) invites you to participate in a conference call on Wednesday, November 5, 2025, at 5:00 p.m. ET to discuss... Read more.